# PanTum Detect diagnostic accuracy study (Max Healthcare, India)

Source: https://onco.cc/trials/pantum-detect-max-healthcare/  
OnCo record `pantum-detect-max-healthcare` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A small Indian study measuring how often the PanTum Detect blood test is positive in people with and without cancer.

## Summary

PanTum Detect diagnostic accuracy study (NCT06456216) is an observational study sponsored by Max Healthcare Insititute Limited. It evaluated the sensitivity and specificity of PanTum Detect for solid tumours in a known cancer population and a cancer-free population.

The registry record, read on 29 October 2026, gives its status as completed, with 90 participants enrolled, a start on 21 February 2022 and primary completion on 14 November 2022.

## Fields

- Kind: Trial
- Status: completed
- Last checked: 2026-10-29
- Registry id: NCT06456216
- Phase: observational
- Setting: People with known solid tumours and cancer-free people at Max Healthcare in India
- Sponsor: Max Healthcare Insititute Limited
- Enrolled: 90

## Sources

- ClinicalTrials.gov NCT06456216: https://clinicaltrials.gov/study/NCT06456216

## Connected records

- fronts: [Early Detection & Screening](https://onco.cc/fronts/early-detection/)
- technologies: [Liquid biopsy (ctDNA)](https://onco.cc/technologies/liquid-biopsy/), [Multi-cancer early detection (MCED)](https://onco.cc/technologies/mced/)
- drugs: [PanTum Detect](https://onco.cc/drugs/pantum-detect/)
- companies: [Zyagnum](https://onco.cc/companies/zyagnum/)

---
JSON: https://onco.cc/api/v1/entities/pantum-detect-max-healthcare.json